XML 38 R23.htm IDEA: XBRL DOCUMENT v3.20.4
Other Balance Sheet Details (Tables)
12 Months Ended
Dec. 31, 2020
Other Balance Sheet Details [Abstract]  
Inventories
Inventories consisted of the following:
December 31,
(in millions)20202019
Raw materials$16.6 $14.1 
Work in process2.4 1.5 
Finished goods9.0 1.7 
Total inventories$28.0 $17.3 
Property and Equipment
Property and equipment, net, consisted of the following:
December 31,
(in millions)20202019
Tenant improvements$29.5 $26.3 
Scientific equipment39.2 33.5 
Computer equipment13.9 12.5 
Furniture and fixtures3.7 3.2 
86.3 75.5 
Less accumulated depreciation(41.7)(33.6)
Total property and equipment, net$44.6 $41.9 
Accounts Payable and Accrued Liabilities
Accounts payable and accrued liabilities consisted of the following:
December 31,
(in millions)20202019
Accrued employee related costs $38.2 $38.9 
Revenue-related reserves for discounts and allowances34.6 30.6 
Accrued development costs32.9 25.5 
Accrued Branded Prescription Drug Fee23.6 4.9 
Accounts payable and other accrued liabilities39.4 41.4 
Total accounts payable and accrued liabilities$168.7 $141.3 
Reconciliation of Cash, Cash Equivalents and Restricted Cash
The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows.
December 31,
(in millions)20202019
Cash and cash equivalents$187.1 $112.3 
Restricted cash3.2 3.2 
Total cash, cash equivalents and restricted cash$190.3 $115.5